Navigation Links
FDA Accepts Endo Pharmaceuticals' Complete Response for New Formulation of OPANA® ER
Date:6/23/2011

CHADDS FORD, Pa., June 23, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of OPANA ER has been accepted. The new formulation was developed in partnership with Grunenthal GmbH and is designed to provide some resistance to certain types of product manipulation. FDA has set a Prescription Drug User Fee Act (PDUFA) date of Dec. 13, 2011.

"We are excited about the opportunity to offer this new formulation of OPANA ER designed to be crush resistant," said Ivan Gergel, M.D., executive vice president, R&D, Endo Pharmaceuticals. "Endo remains dedicated to improving patient care and the appropriate clinical use of opioid analgesics through access to treatment and a proactive approach to managing the potential risks inherent in opioid therapy."

Important information about OPANA® ER

OPANA ER is indicated for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time and is not intended for use as an as needed analgesic.

OPANA ER is not indicated for pain in the immediate post-operative period (12-24 hours following surgery) for patients not previously taking opioids because of the risk of over sedation and respiratory depression requiring reversal with opioid antagonists. OPANA ER is not indicated for pain in the post-operative period if the pain is mild or not expected to persist for an extended period of time.

OPANA® ER has a boxed warning as follows:

WARNING: OPANA ER contains oxymorphone, which is a morphine-like opioid agonist and a Schedule II controlled substance, with an abuse liability similar to oth
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
2. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
3. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
4. FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
5. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
6. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
7. FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)
8. FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review
9. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
10. FDA Accepts Sanofi Pasteurs Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
11. FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015  Over the next five years, the ... grow, with ArcView predicting that 14 more states will legalize ... The U.S. market for legal cannabis grew 74 percent in ... Analysts project the market could grow more than fourfold to ... soften their stance on marijuana. Cannabiz Mobile Inc. ...
(Date:4/17/2015)... April 17, 2015 Today, the Pharmaceutical ... employees from 12 biopharmaceutical companies as "We Work ... policy advocacy and community service. Established ... Awards were created by the biopharmaceutical industry to ... their careers, but have also shown an outstanding ...
(Date:4/17/2015)... , April 17, 2015   IBA ... of radiopharmaceuticals, announced today that it has signed a ... North America, Inc. (IBAM NA), to Illinois Health and Science ... operate as an independent company headquartered in ... to take advantage of new product and footprint synergies. ...
Breaking Medicine Technology:Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3
... Md., Sept. 11 Northwest,Biotherapeutics, Inc. (OTC Bulletin ... "Company") today announced the most recent long-term,follow-up data, ... I and Phase,I/II clinical trials with DCVax(R)-Brain, which ... multiforme, the most lethal type of brain,cancer. This ...
... AUSTIN, Texas, Sept. 10 The first-ever human,clinical ... tea was,recently conducted, testing whether the tea can ... new trial also generated the first human safety ... that,short-term consumption of rooibos tea is safe for ...
Cached Medicine Technology:Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 2Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 3Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 4Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 5Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 6Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 2Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 3Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 4Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 5
(Date:4/18/2015)... Raleigh, NC (PRWEB) April 18, 2015 ... the risk of developing mesothelioma later in life, but ... ways from mesothelioma that is unrelated to radiation. Surviving ... study on its website. Click here to read ... and Australia compared the cases of 45 patients who ...
(Date:4/18/2015)... April 18, 2015 Aureus Medical ... staffing, including physical therapy jobs, has announced that ... South Carolina Physical Therapy Association Annual Conference to ... Center in Greenville, SC. , The SCAPTA ... exhibits with products and services. , Representatives ...
(Date:4/17/2015)... Bradley, Illinois (PRWEB) April 17, 2015 ... host a Party on the Patio from 2 p.m. ... which is located at 1320 Executive Ct. in Pekin, ... on Medicaid, who need some help to maintain their ... steel drums, and tropical treats will be served during ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at ... were all selected as Top Workplaces in Tampa Bay. ... is ranked number one for large businesses according to ... in partnership with an independent research firm. Florida Hospital ... opened in October of 2012 with a vision of ...
(Date:4/17/2015)... April 17, 2015 Representatives Jim Himes ... and Treatment Act HR 1849 in congress on April ... and treatment for patients with the genetic disease. ... past, would be the first to create a federally ... treatment of hereditary hemorrhagic telangiectasia. This would effectively prevent ...
Breaking Medicine News(10 mins):Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:House Representatives Introduce Bill to Fight Genetic Disease 2
... 2010) High doses of antioxidant nutritional supplements, such ... cells, which may predispose supplement-takers to developing cancer, according to ... The study, led by Eduardo Marbn, M.D., Ph.D., director ... the medical journal Stem Cells . The study ...
... find early stage cancers and precancerous growths than current ... -- Noninvasive stool DNA testing can detect two types ... in colon cancer prevention, say two new studies. , ... testing has higher detection rates for curable stage colorectal ...
... readmissions, study finds , TUESDAY, May 4 (HealthDay News) -- ... heart failure patient discharged from the hospital reduces the chance ... but that preventive measure is more often ignored than observed, ... 30,000 hospital patients covered by Medicare found that fewer than ...
... CINCINNATIThe popular diabetes medication metformin works in different fashion ... could lead to wider use of the drugparticularly in ... like tuberous sclerosis and lymphangioleiomyomatosis (LAM). The ... scientific director of UC,s Metabolic Diseases Institute, are published ...
... many times have you, after a particularly hard day, reached ... people, but for those trying to lose weight, it can ... programs never even address it. They focus on choosing ... key question: how can people who have eaten to cope ...
... ... cleaning machine that combines high impact cleaning efficiency with extended operating life, reduced life cycle ... can be completely stripped and rebuilt for maintenance ON-SITE in less than 15 minutes. ... (PRWEB) May 4, 2010 -- ...
Cached Medicine News:Health News:High doses of antioxidant supplements induce stem cell genetic abnormalities 2Health News:New Test for Colon Cancer Under Development 2Health News:Hospitals Falling Short on Heart Patients' Follow-Up Care 2Health News:Popular diabetes drug works differently than thought 2Health News:Managing the emotions behind eating 2Health News:BETE Fog Nozzle Announces HydroWhirl™ Orbitor – Clean-In-Place Rotating Tank Cleaning Machine with High Impact Cleaning for Extended Operating Life 2
Illuminated Phoroptor Refracting Instrument. Illumination is provided by a cool-running, energy efficient LEDs (Light Emitting Diodes) that light only what you need to see without affecting the darke...
Double Maddox...
Maddox Rod, short handle (12cm)...
... The Snellen chart remains to most ... range of different optotypes can be ... sheridan-gardner, landolt Cs, tumbling Es and ... column can be shown and a ...
Medicine Products: